BridgeMD
New treatment option for Spastic Cerebral Palsy (sCP)
Official title Talocrural Mobilization With Movement in Spastic Cerebral Palsy
ClinicalTrials.gov ID: NCT06598657
What this study is testing
- What it's testing
- The aim of this randomized controlled trial is to find the effect of Mulligan's Mobilization with Movement of Talocrural joint in Cerebral Palsy Patients having spasticity on improving Ankle Range of Motion, improving balance and its effect on Gait speed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 18
You may be able to join if
- Both genders
- Age group 8-18 years
- Diagnosis of spastic Cerebral Palsy
- CP to follow verbal directions
- Modified Ashworth Scale score of '1' or '1+'
You likely can't join if
- visual, hearing disorders
- verbal and cognitive disorders (unable to comprehend commands)
- recent lower extremity surgery
- botulinum toxin injection
See the full eligibility criteria
- Both genders
- Age group 8-18 years
- Diagnosis of spastic Cerebral Palsy
- CP to follow verbal directions
- Modified Ashworth Scale score of '1' or '1+'
- Function classification system (GMFCS) level I or II ability to walk
- 10 m or more independently
- visual, hearing disorders
- verbal and cognitive disorders (unable to comprehend commands)
- recent lower extremity surgery
- botulinum toxin injection
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.